Clinical Trial
2020 Nov 7;41(42):4114-4123.
JOURNAL：Eur Heart J.
Article Link
Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial
J Tuñón, PG Steg, ODYSSEY OUTCOMES Investigators et al.
KEYWORDS
chronic kidney disease; glomerular filtration rate; Low-density lipoprotein cholesterol; MACE; PCSK9 inhibition
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
